High NFL levels in peripheral biofluids (serum, plasma or CSF) are considered a biomarker for axonal degeneration, and there is considerable evidence that motor dysfunction in PD relates to high peripheral NFL levels that occur in concert with nigrostriatal degeneration [6, 25]. The gene discussed is NEFL; the disease is Parkinson disease.